SEARCH

SEARCH BY CITATION

REFERENCES

  • Aberhart DJ, Chi-Tung Hsu A. 1976. Studies on the adduct of 4-phenyl-1,2,4-triazoline-3,5-dione with vitamin D3. J Org Chem 41:20982102.
  • AB-Sciex. 2013. Ampliflex™—Diene. http://www.sciex.com/products/standards-and-reagents/amplifex-diene-reagent. Acessed 13 March 2013.
  • Adamec J, Jannasch A, Huang J, Hohman E, Fleet JC, Peacock M, Ferruzzi MG, Martin B, Weaver CM. 2011. Development and optimization of an LC-MS/MS-based method for simultaneous quantification of vitamin D2, vitamin D3, 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3. J Sep Sci 34:1120.
  • Alder L, Lüderitz S, Lindtner K, Stan H-J. 2004. The ECHO technique—The more effective way of data evaluation in liquid chromatography–tandem mass spectrometry analysis. J Chromatogr A 1058:6779.
  • Armas LAG, Hollis BW, Heaney RP. 2004. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89:53875391.
  • Aronov PA, Hall LM, Dettmer K, Stephensen CB, Hammock BD. 2008. Metabolic profiling of major vitamin D metabolites using diels-alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 391:19171930.
  • Baecher S, Leinenbach A, Wright JA, Pongratz S, Kobold U, Thiele R. 2012. Simultaneous quantification of four vitamin D metabolites in human serum using high performance liquid chromatography tandem mass spectrometry for vitamin D profiling. Clin Biochem 25:611.
  • Bedner M, Phinney KW. 2012. Development and comparison of three liquid chromatography-atmospheric pressure chemical ionization/mass spectrometry methods for determining vitamin D metabolites in human serum. J Chromatogr A 1240:132139.
  • Binkley N, Krueger DC, Morgan S, Wiebe D. 2010. Current status of clinical 25-hydroxyvitamin D measurement: An assessment of between-laboratory agreement. Clin Chim Acta 411:19761982.
  • Bischof MG, Siu-Caldera ML, Weiskopf A, Vouros P, Cross HS, Peterlik M, Reddy GS. 1998. Differentiation-related pathways of 1 alpha,25-dihydroxycholecalciferol metabolism in human colon adenocarcinoma-derived Caco-2 Cells: Production of 1 alpha,25-dihydroxy-3epi-cholecalciferol. Exp Cell Res 241:194201.
  • Bogusz MJ, Al Enazi E, Tahtamoni M, Jawaad JA, Al Tufail M. 2011. Determination of serum vitamins 25-OH-D2 and 25-OH-D3 with liquid chromatography-tandem mass spectrometry using atmospheric pressure chemical ionization or electrospray source and core-shell or sub-2 μm particle columns: A comparative study. Clin Biochem 44:13291337.
  • Bosworth CR, Levin G, Robinson-Cohen C, Hoofnagle AN, Ruzinski J, Young B, Schwartz SM, Himmelfarb J, Kestenbaum B, de Boer IH. 2012. The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease. Kidney Int 82:693700.
  • Brombacher S, Volmer DA. 2003. Ion trap tandem mass spectrometry of biological molecules using wide range excitation CID. J Mass Spectrom 38:687689.
  • Brown AJ, Ritter C, Slatopolsky E, Muralidharan KR, Okamura WH, Reddy GS. 1999. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion. J Cell Biochem 73:106113.
  • Bruce SJ, Rochat B, Béguin A, Pesse B, Guessous I, Boulat O, Henry H. 2013. Analysis and quantification of vitamin D metabolites in serum by ultra-performance liquid chromatography coupled to tandem mass spectrometry and high-resolution mass spectrometry—A method comparison and validation. Rapid Commun Mass Spectrom 27:200206.
  • Bunch DR, Miller AY, Wang S. 2009. Development and validation of a liquid chromatography-tandem mass spectrometry assay for serum 25-hydroxyvitamin D2/D3 using a turbulent flow online extraction technology. Clin Chem Lab Med 47:15651572.
  • Cai S-S, Syage JA. 2006a. Atmospheric pressure photoionization mass spectrometry for analysis of fatty acid and acylglycerol lipids. J Chromatogr A 1110:1526.
  • Cai S-S, Syage JA. 2006b. Comparison of atmospheric pressure photoionization, atmospheric pressure chemical ionization, and electrospray ionization mass spectrometry for analysis of lipids. Anal Chem 78:11911199.
  • Careri M, Lugari MT, Mangia A, Manini P, Spagnoli S. 1995. Identification of vitamins A, D and E by particle beam liquid chromatography-mass spectrometry. Fresenius J Anal Chem 351:768776.
  • Carter GD. 2009. 25-Hydroxyvitamin D assays: The quest for accuracy. Clin Chem 55:13001302.
  • Carter GD. 2011. Accuracy of 25-hydroxyvitamin D assays: Confronting the issues. Curr Drug Targets 12:1928.
  • Carter GD. 2012. 25-Hydroxyvitamin D: A difficult analyte. Clin Chem 58:486488.
  • Carter GD, Jones JC. 2009. Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann Clin Biochem 46:7981.
  • Carter GD, Carter CR, Gunter E, Jones J, Jones G, Makin HLJ, Sufi S. 2004. Measurement of vitamin D metabolites: An international perspective on methodology and clinical interpretation. Steroid Biochem Mol Biol 89–90:467471.
  • Carter GD, Berry JL, Gunter E, Jones G, Jones JC, Makin HLJ, Sufi S, Wheeler MJ. 2010. Proficiency testing of 25-hydroxyvitamin D (25-OHD) assays. J Steroid Biochem Mol Biol 121:176179.
  • Chen TC, Chimeh F, Lu Z, Mathieu J, Person KS, Zhang A, Kohn N, Martinello S, Berkowitz R, Hollick MF. 2007. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys 460:213217.
  • Chen H, McCoy LF, Schleicher RL, Pfeiffer CM. 2008. Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method. Clin Chim Acta 391:612.
  • Couchman L, Benton CM, Moniz CF. 2012. Variability in the analysis of 25-hydroxyvitamin D by liquid chromatography-tandem mass spectrometry: The devil is in the detail. Clin Chim Acta 413:12391243.
  • Crawford BA, Labio ED, Strasser SI, McCaughan GW. 2006. Vitamin D replacement for cirrhosis-related bone disease. Nat Clin Pract Gastroenterol Hepatol 3:689699.
  • Davey Smith G, Ebrahim S. 2003. ‘Mendelian randomization’: Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32:122.
  • De Koning LM, Al-Turkmani RM, Berg AH, Shkreta A, Law T, Kellogg MD. 2013. Variation in clinical vitamin D status by DiaSorin Liaison and LC-MS/MS in the presence of elevated 25-OH vitamin D2. Clin Chim Acta 415:5458.
  • De la Hunty A, Wallace MA, Gibson S, Viljakainen H, Lamberg-Allardt C, Ashwell M. 2010. UK Food Standards Agency Workshop Consensus Report: The choice of method for measuring 25-hydroxyvitamin D to estimate vitamin D status for the UK National Diet and Nutrition Survey. Br J Nutr 104:612619.
  • Demetriou ETW, Travison TG, Hollick MF. 2012. Treatment with 50,000 IU vitamin D every other week and effect on serum 25-hydroxyvitamin D, 25-hydroxyvitamin D, and total 25-hydroxyvitamin D in a clinical setting. Endocr Pract 18:399402.
  • Ding S, Schoenmakers I, Jones K, Koulman A, Prentice A, Volmer DA. 2010. Quantitative determination of vitamin D metabolites in plasma using UHPLC-MS/MS. Anal Bioanal Chem 398:779789.
  • Donkena KV, Young CYF. 2011. Vitamin D, sunlight and prostate cancer risk. Adv Prev Med 2011:281863.
  • Down PF, Polak A, Regan RJ. 1979. A family with massive acute vitamin D intoxication. Postgrad Med J 55:897902.
  • Duan X, Weinstock-Guttman B, Wang H, Bang E, Li J, Ramanathan M, Qu J. 2010. Ultrasensitive quantification of serum vitamin D metabolites using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass spectrometry. Anal Chem 82:24882497.
  • Eisman JA, DeLuca HF. 1978. Determination of vitamin D metabolites. Methods Enzymol 52:388398.
  • El-Khoury JM, Reineks EZ, Wang S. 2011. Progress of liquid chromatography-mass spectrometry in measurement of vitamin D metabolites and analogues. Clin Biochem 44:6676.
  • Ersfeld DL, Sudhaker Rao D, Body J-J, Sackrison JL, Miller AB, Parikh N, Eskridge TL, Polinske A, Olson GT, MacFarlane GD. 2004. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem 37:867874.
  • Eyles D, Anderson C, Ko P, Jones A, Thomas A, Burne T, Mortensen PB, Nørgaard-Pedersen B, Hougaard DM, McGrath J. 2009. A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. Clin Chim Acta 403:145151.
  • Faurschou A, Beyer DM, Schmedes A, Bogh MK, Philipsen PA, Wulf HC. 2012. The relation between sunscreen layer thickness and vitamin D production after ultraviolet B exposure: A randomized clinical trial. Br J Dermatol 167:391395.
  • Fraser WD, Milan AM. 2013. Vitamin D assays: Past and present debates, difficulties, and developments. Calcif Tissue Int 92:118127.
  • Gal-Moscovici A, Sprague SM. 2007. Role of vitamin D deficiency in chronic kidney disease. J Bone Miner Res 22:9194.
  • Gathungu RM, Flarakos CC, Satyanarayana Reddy G, Vouros P. 2013. The role of mass spectrometry in the analysis of vitamin D compounds. Mass Spectrom Rev 32:7286.
  • Golbahar J, Al-Saffar N, Diab DA, Al-Othman S, Darwish A, Al-Kafaji G. 2013. Predictors of vitamin D deficiency and insufficiency in adult bahrainis: A cross-sectional study. Public Health Nutr 25:17.
  • Gören AC, Bilsel G, Bilsel M. 2007. Rapid and simultaneous determination of 25-OH-vitamin D 2 and D 3 in human serum by LC/MS/MS: Validation and uncertainty assessment. J Chem Metrl 1:19.
  • Grebe SK, Singh RJ. 2011. LC-MS/MS in the clinical laboratory—Where to from here? Clin Biochem Rev 32:531.
  • Gröber U, Kisters K. 2012. Influence of drugs on vitamin D and calcium metabolism. Dermatoendocrinol 4:158166.
  • Gross JH. 2004. Mass spectrometry—A textbook. Springer, Berlin Heidelberg.
  • Grünhage F, Hochrath K, Krawczyk M, Höblinger A, Obermayer-Pietsch B, Geisel J, Trauner M, Sauerbruch T, Lammert F. 2012. Common genetic variation in vitamin D metabolism is associated with liver stiffness. Hepatology 56:18831891.
  • Gueli N, Verrusio W, Linguanti A, Di Maio F, Martinez A, Marigliano B, Cacciafesta M. 2012. Vitamin D: Drug of the future. A new therapeutic approach. Arch Gerontol Geriatr 54:222227.
  • Ham Bryan M. 2008. Even electron mass spectrometry with biomolecule applications. Hoboken: Wiley.
  • Herrmann M, Harwood T, Gaston-Parry O, Kouzios D, Wong T, Lih A, Jimenez M, Janu M, Seibel MJ. 2010. A new quantitative LC tandem mass spectrometry assay for serum 25-hydroxy vitamin D. Steroids 75:11061112.
  • Higashi T. 2006. Trace determination of steroids causing age-related diseases using LC/MS combined with detection-oriented derivatization. Chem Pharm Bull 54:14791485.
  • Higashi T, Awada D, Shimada K. 2001a. Determination of 24,25-dihydroxyvitamin D3 in human plasma using liquid chromatography-mass spectrometry after derivatization with a Cookson-type reagent. Biomed Chromatogr 15:133140.
  • Higashi T, Awada D, Shimada K. 2001b. Simultaneous determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma by liquid chromatography-tandem mass spectrometry employing derivatization with a Cookson-type reagent. Biol Pharm Bull 24:738743.
  • Higashi T, Shibayama Y, Fuji M, Shimada K. 2008. Liquid chromatography-tandem mass spectrometric method for the determination of salivary 25-hydroxyvitamin D3: A noninvasive tool for the assessment of vitamin D status. Anal Bioanal Chem 391:229238.
  • Higashi T, Suzuki M, Hanai J, Inagaki S, Jun ZM, Shimada K, Toyo'oka T. 2011. A specific LC/ESI-MS/MS method for determination of 25-hydroxyvitamin D3 in neonatal dried blood spots containing a potential interfering metabolite, 3-epi-25-hydroxyvitamin D3. J Sep Sci 34:725732.
  • Højskov CS, Heickendorff L, Møller HJ. 2010. High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory. Clin Chim Acta 411:114116.
  • Hollick MF. 1995. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 61:638S645S.
  • Hollick MF. 2005a. Stay tuned to PXR: An orphan actor that may not be D-structive only to bone. J Clin Invest 115:3234.
  • Hollick MF. 2005b. The vitamin D epidemic and its health consequences. J Nutr 135:2739S2748S.
  • Hollick MF. 2007. Vitamin D deficiency. N Engl J Med 357:2662281.
  • Hollick MF. 2008. Vitamin D and sunlight: Strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol 3:15481554.
  • Hollick MF. 2009. Vitamin D status: Measurement, interpretation, and clinical application. Ann Epidemiol 19:7378.
  • Hollick MF. 2010. The D-lemma: To screen or not to screen for 25-hydroxyvitamin D concentrations. Clin Chem 56:729731.
  • Hollick MF, MacLaughlin JA, Clark MB, Holick SA, Potts JT, Anderson RR, Blank IH, Parrish JA, Elias P. 1980. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 210:203205.
  • Hollick MF, MacLaughlin JA, Doppelt SH. 1981. Regulation of cutaneous previtamin D3 photosynthesis in man: Skin pigment is not an essential regulator. Science 211:590593.
  • Hollick MF, Tian XQ, Allen M. 1995. Evolutionary importance for the membrane enhancement of the production of vitamin D3 in the skin of poikilothermic animals. Proc Natl Acad Sci USA 92:31243126.
  • Hollick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. 2011. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:19111930.
  • Hollis BW. 2000. Comparison of commercially available (125)I-based RIA methods for the determination of circulating 25-hydroxyvitamin D. Clin Chem 46:16571661.
  • Hollis BW. 2008. Measuring 25-hydroxyvitamin D in a clinical environment: Challenges and needs. Am J Clin Nutr 88:507S510S.
  • Hollis BW, Horst RL. 2007. The assessment of circulating 25(OH)D and 1,25(OH)2D: Where we are and where we are going. J Steroid Biochem Mol Biol 103:473476.
  • Hoofnagle AN, Laha TJ, Donaldson TF. 2010. A rubber transfer gasket to improve the throughput of liquid-liquid extraction in 96-well plates: Application to vitamin D testing. J Chromatogr B 878:16391642.
  • Horst RL, Koszewski NJ, Reinhardt TA. 1990. 1 Alpha-hydroxylation of 24-hydroxyvitamin D2 represents a minor physiological pathway for the activation of vitamin D2 in mammals. Biochemistry 29:578582.
  • Houghton LA, Vieth R. 2006. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 84:694697.
  • Ikekawa N, Koizumi N. 1976. Separation of vitamin D metabolites and their analogues by high-pressure liquid chromatography. J Chromatogr 119:227232.
  • Institute of Medicine. 2011. Dietary references intakes for calcium and vitamin D. Washington, DC: National Academies Press.
  • Jablonski NG, Chaplin G. 2000. The evolution of human skin coloration. J Hum Evol 39:57106.
  • Jacobus CH, Hollick M, Shao Q, Chen TC, Holm IA, Kolodny JM, Fuleihan GE, Seely EW. 1992. “ Hypervitaminosis D associated with drinking milk. N Engl J Med 326:11731177.
  • JCTLM. 2013. JCTLM: Joint Committee for Traceability in Laboratory Medicine. http://www.bipm.org/jctlm. Accessed 13 March 2013.
  • Jessome LL, Volmer DA. 2006. Ion suppression: A major concern in mass spectrometry. LCGC North America 24:498510.
  • Jones G. 2008. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 88:582S586S.
  • Jones G, DeLuca HF. 1975. High-pressure liquid chromatography: Separation of the metabolites of vitamins D2 and D3 on small-particle silica columns. J Lipid Res 16:448453.
  • Jones G, Schnoes HK, Levan L, Deluca HF. 1980. Isolation and identification of 24-hydroxyvitamin D2 and 24,25-dihydroxyvitamin D2. Arch Biochem Biophys 202:450457.
  • Kamao M, Tatematsu S, Hatakeyama S, Sakaki T, Sawada N, Inouye K, Ozono K, Kubodera N, Reddy GS, Okano T. 2004a. C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-Hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation. J Biol Chem 279:1589715907.
  • Kamao M, Tatematsu S, Sawada N, Sakaki T, Hatakeyama S, Kubodera N, Okano T. 2004b. Cell specificity and properties of the C-3 epimerization of vitamin D3 metabolites. J Steroid Biochem Mol Biol 89–90:3942.
  • Keevil B. 2012. Does the presence of 3-epi-25OHD3 affect the routine measurement of vitamin D using liquid chromatography tandem mass spectrometry? Clin Chem Lab Med 50:181183.
  • Kimlin MG. 2008. Geographic location and vitamin D synthesis. Mol Aspects Med 29:453461.
  • Koulman A, Petras D, Narayana VK, Wang L, Volmer DA. 2009. Comparative high-speed profiling of carboxylic acid metabolite levels by differential isotope-coded MALDI mass spectrometry. Anal Chem 81:75447551.
  • Koyyalamudi SR, Jeong S-C, Song C-H, Cho KY, Pang G. 2009. Vitamin D2 formation and bioavailability from agaricus bisporus button mushrooms treated with ultraviolet irradiation. J Agric Food Chem 57:33513355.
  • Kushnir MM, Ray JA, Rockwood AL, Roberts WL La'ulu SL, Whittington JDE, Meikle AW. 2010. Rapid analysis of 25-hydroxyvitamin D(2) and D(3) by liquid chromatography-tandem mass spectrometry and association of vitamin D and parathyroid hormone concentrations in healthy adults. Am J Clin Pathol 134:148156.
  • Lensmeyer G, Poquette M, Wiebe D, Binkley N. 2012. The C-3 epimer of 25-hydroxyvitamin D(3) is present in adult serum. J Clin Endocrinol Metab 97:163168.
  • Linos E, Keiser E, Kanzler M, Sainani KL, Lee W, Vittinghoff E, Chren M-M, Tang JY. 2012. Sun protective behaviors and vitamin D levels in the US population: NHANES 2003–2006. Cancer Causes Control 23:133140.
  • Lipkie TE, Janasch A, Cooper BR, Hohman EE, Weaver CM, Ferruzzi MG. 2013. Quantification of vitamin D and 25-hydroxyvitamin D in soft tissues by liquid chromatography-tandem mass spectrometry. J Chromatogr B 932:611.
  • MacLaughlin J, Hollick MF. 1985. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Inest 76:15361538.
  • Malvy DJ, Guinot C, Preziosi P, Galan P, Chapuy MC, Maamer M, Arnaud S, Meunier PJ, Hercberg S, Tschachler E. 2000. Relationship between vitamin D status and skin phototype in general adult population. Photochem Photobiol 71:466469.
  • Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Hollick MF. 1987. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 64:11651168.
  • Matsuoka LY, Wortsman J, Dannenberg MJ, Hollis BW, Lu Z, Hollick MF. 1992. Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endorinol Metab 75:10991103.
  • Maunsell Z, Wright DJ, Rainbow SJ. 2005. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 51:16831690.
  • Mawer EB, Backhouse J, Holman CA, Lumb GA, Stanbury SW. 1972. The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci 43:413431.
  • McAree T, Jacobs B, Manickavasagar T, Sivalokanathan S, Brennan L, Bassett P, Rainbow S, Blair M. 2013. Vitamin D deficiency in pregnancy—Still a public health issue. Mat Child Nutr 9:2330.
  • METLIN. 2013. METLIN (Metabolite and Tandem MS Database). http://metlin.scripps.edu. Accessed 13 March 2013.
  • Molnár F, Sigüeiro R, Sato Y, Araujo C, Schuster I, Antony P, Peluso J, Muller C, Mouriño A, Moras D, Rochel N. 2011. 1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: Its synthesis, biological activity and crystal structure with its receptor. PLoS ONE 6:e18124.
  • Moon H-W, Cho J-H, Hur M, Song J, Oh GY, Park CM, Yun Y-M, Kim JQ. 2012. Comparison of four current 25-hydroxyvitamin D assays. Clin Biochem 45:326330.
  • Mulholland M, Whelan TJ, Rose H, Keegan J. 2000. Direct identification and quantitation of prednisone in the presence of overlapping hydrocortisone by liquid chromatography with electrospray and atmospheric-pressure chemical-ionisation mass spectrometry. J Chromatogr A 870:135141.
  • Nagpal S, Na S, Rathnachalam R. 2005. Noncalcemic actions of vitamin D receptor ligands. Endocrine Rev 26:662687.
  • Nakagawa K, Sowa Y, Kurobe M, Ozono K, Siu-Caldera ML, Reddy GS, Uskokovic MR, Okano T. 2001. Differential activities of 1alpha,25-dihydroxy-16-ene-vitamin D(3) analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis. Steroids 66:327337.
  • Nakamura T, Kurokawa T, Orimo H. 1989. Increased mechanical strength of the vitamin D-replete rat femur by the treatment with a large dose of 24R,25(OH)2D3. Bone 10:117123.
  • Nesby-O'Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC, Allen C, Doughertly C, Gunter EW, Bowman B. 2002. Hypovitaminosis D prevalence and determinants among African American and White women of reproductive age: Third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr 76:187192.
  • Netzel BC, Cradic KW, Bro ET, Girtman AB, Cyr RC, Singh RJ, Grebe SKG. 2011. Increasing liquid chromatography-tandem mass spectrometry throughput by mass tagging: A sample-multiplexed high-throughput assay for 25-hydroxyvitamin D2 and D3. Clin Chem 57:431440.
  • Newman MS, Brandon TR, Groves MN, Gregory WL, Kapur S, Zava DT. 2009. A liquid chromatography/tandem mass spectrometry method for determination of 25-hydroxy vitamin D2 and 25-hydroxy vitamin D3 in dried blood spots: A potential adjunct to diabetes and cardiometabolic risk screening. J Diabete Sci Technol 3:156162.
  • NIST. 2013. NIST—Standard reference materials. http://www.nist.gov/srm/index.cfm. Accessed 13 March 2013.
  • Plum LA, DeLuca HF. 2009. The functional metabolism and molecular biology of vitamin D action. Clin Rev Bone Miner Metab 7:2041.
  • Prentice A, Goldberg GR, Schoenmakers I. 2008. Vitamin D across the lifecycle: Physiology and biomarkers. Am J Clin Nutr 88:500S506S.
  • Reddy GS, Muralidharan KR, Okamura WH, Tserng KY, McLane JA. 2001. Metabolism of 1alpha,25-dihydroxyvitamin D(3) and its C-3 epimer 1alpha,25-dihydroxy-3-epi-vitamin D(3) in neonatal human keratinocytes. Steroids 66:441450.
  • Rehan VK, Torday JS, Sara P, Lynn G, Vouros P, Padbury JD, Rao DS, Reddy GS. 2002. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxy vitamin D3: Production and biological activity studies in pulmonary alveolar type II cells. Mol Gen Metab 76:4656.
  • Robins AH. 2009. The evolution of light skin color: Role of vitamin D disputed. Am J Phys Anthropol 139:447450.
  • Saenger AK, Laha TJ, Bremner DE, Sadrzadeh SM. 2006. Quantification of serum 25-hydroxyvitamin D2 and D3 using HPLC-tandem mass spectrometry and examination of reference intervals for diagnosis of vitamin D deficiency. Am J Clin Pathol 125:914920.
  • Sato K, Emoto N, Toraya S, Tsushima T, Demura H, Tsuji N, Inaba S, Takeuchi A, Kobayashi T. 1994. Progressively increased serum 1,25-dihydroxyvitamin D2 concentration in a hypoparathyroid patient with protracted hypercalcemia due to vitamin D2 intoxication. Endocrine J 41:329337.
  • Schleicher RL, Encisco SE, Chaudhary-Webb M, Paliakov E, McCoy LF, Pfeiffer CM. 2011. Isotope dilution ultra performance liquid chromatography-tandem mass spectrometry method for simultaneous measurement of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3 and 3-epi-25-hydroxyvitamin D3 in human serum. Clin Chim Acta 412:15941599.
  • Sempos CT, Vesper HW, Phinney KW, Thienpont LM, Coates PM. 2012. Vitamin D status as an international issue: National surveys and the problem of standardization. Scand J Clin Lab Invest 243:3240.
  • Seo EG, Einhorn TA, Norman AW. 1997. 24R,25-dihydroxyvitamin D3: An essential vitamin D3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Endocrinology 138:38643872.
  • Shah I, James R, Barker J, Petroczi A, Naughton DP. 2011. Misleading measures in vitamin D analysis: A novel LC-MS/MS assay to account for epimers and isobars. Nutr J 10:46.
  • Shimada K, Oe T, Mizuguchi T. 1991. Cookson-type reagents: Highly sensitive derivatization reagents for conjugated dienes in high-performance liquid chromatography. Analyst 116:13931397.
  • Shipowick CD, Moore BC, Corbett C, Bindler R. 2009. Vitamin D and depressive symptoms in women during the winter: A pilot study. Appl Nurs Res 22:221225.
  • Singh RJ, Taylor RL, Reddy GS, Grebe SKG. 2006. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 91:30553061.
  • Siu-Caldera ML, Sekimoto H, Weiskopf A, Vouros P, Muralidharan KR, Okamura WH, Bishop J, Norman AW, Uskoković MR, Schuster I, Reddy GS. 1999. Production of 1alpha,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): Existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed. Bone 24:457463.
  • Sleno L, Volmer DA, Marshall AG. 2005. Assigning product ions from complex MS/MS spectra: The importance of mass uncertainty and resolving power. J Am Soc Mass Spectrom 16:183198.
  • St-Arnaud R, Gloriueux FH. 1998. 24,25-Dihydroxyvitamin D-active metabolite or inactive catabolite? Endocrinology 139:33713374.
  • St-Arnaud R, Arabian A, Travers R, Barletta F, Raval-Pandya M, Chapin K, Depovere J, Mathieu C, Christakos S, Demay MB, Glorieux FH. 2000. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 141:26582666.
  • Stepman HCM, Vanderroost A, Stöckl D, Thienpont LM. 2011a. Full-scan mass spectral evidence for 3-epi-25-hydroxyvitamin D3 in serum of infants and adults. Clin Chem Lab Med 49:253256.
  • Stepman HCM, Vanderroost A, Van Uytfanghe K, Thienpont LM. 2011b. Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem 57:441448.
  • Stokes CS, Volmer D, Grünhage F, Lammert F. 2013. Vitamin D in chronic liver disease. Liver Int 33:338352.
  • Strathmann FG, Sadilkova K, Laha TJ, LeSourd SE, Bornhorst JA, Hoofnagle AN, Jack R. 2012. 3-epi-25 Hydroxyvitamin D concentrations are not correlated with age in a cohort of infants and adults. Clin Chim Acta 413:203206.
  • Tai SS-C, Bedner M, Phinney KW. 2010. Development of a candidate reference measurement procedure for the determination of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Chem 82:19421948.
  • Thevis M, Volmer DA. 2012. Recent instrumental progress in mass spectrometry: Advancing resolution, accuracy, and speed of drug detection. Drug Test Anal 4:242245.
  • Thibeault D, Caron N, Djiana R, Kremer R, Blank D. 2012. Development and optimization of simplified LC-MS/MS quantification of 25-hydroxyvitamin D using protein precipitation combined with on-line solid phase extraction (SPE). J Chromatogr B 883–884:120127.
  • Thompson RM, Foley PA, Jolley D, Knight KR, Harrison J, Sandra C. 1995. The effect of regular sunscreen use on vitamin D levels in an Australian population. Arch Dermatol 131:415421.
  • Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. 1998. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 68:854858.
  • Trémezaygues L, Reichrath J. 2011. From the bench to emerging new clinical concepts: Our present understanding of the importance of the Vitamin D Endocrine System (VDES) for skin cancer. Dermatoendocrinol 3:1117.
  • Tsiaras WG, Weinstock MA. 2011. Factors influencing vitamin D status. Acta Derm Venereol 91:115124.
  • Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y. 2009. Validation of bioanalytical LC-MS/MS assays: Evaluation of matrix effects. J Chromatogr B 877:21982207.
  • Vicchio D, Yergey A, O'Brien K, Allen L, Ray R, Holick M. 1993. Quantification and kinetics of 25-hydroxyvitamin D3 by isotope dilution liquid chromatography/thermospray mass spectrometry. Biol Mass Spectrom 22:5358.
  • Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, Hiraki LT, Cooper JD, Dastani Z, Li R, Houston DK, Wood AR, Michaëlsson K, Vandenput L, Zgaga L, Yerges-Armstrong LM, McCarthy MI, Dupuis J, Kaakinen M, Kleber ME, Jameson K, Arden N, Raitakari O, Viikari J, Lohman KK, Ferrucci L, Melhus H, Ingelsson E, Byberg L, Lind L, Lorentzon M, Salomaa V, Campbell H, Dunlop M, Mitchell BD, Herzig KH, Pouta A, Hartikainen AL, Genetic Investigation of Anthropometric Traits-GIANT Consortium, Streeten EA, Theodoratou E, Jula A, Wareham NJ, Ohlsson C, Frayling TM, Kritchevsky SB, Spector TD, Richards JB, Lehtimäki T, Ouwehand WH, Kraft P, Cooper C, März W, Power C, Loos RJ, Wang TJ, Järvelin MR, Whittaker JC, Hingorani AD, Hyppönen E. 2013. Causal relationship between obesity and vitamin D status: Bi-directional mendelian randomization analysis of multiple cohorts. PLoS Med 10:e1001383.
  • Vogeser M, Kyriatsoulis A, Huber E, Kobold U. 2004. Candidate reference method for the quantification of circulating 25-hydroxyvitamin D3 by liquid chromatography-tandem mass spectrometry. Clin Chem 50:14151417.
  • Vreeken RJ, Honing M, van Baar BL, Ghijsen RT, de Jong GJ, Brinkman UA. 1993. On-line post-column Diels-Alder derivatization for the determination of vitamin D3 and its metabolites by liquid chromatography/thermospray mass spectrometry. Biol Mass Spectrom 22:621632.
  • Wandaus A, Thiele W. 1935. Über Die Konstitution Des vitamins D2. Ann Chem 527:160175.
  • Wang K, Davis PP, Crews T, Gabriel L, Edom RW. 1996. An electron-capture dienophile derivatization agent for increasing sensitivity: Determination of a vitamin D analog (Ro 24-2090) in Plasma samples with liquid chromatography/mass spectrometry. Anal Biochem 243:2840.
  • Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, Kiel DP, Streeten EA, Ohlsson C, Koller DL, Peltonen L, Cooper JD, O'Reilly PF, Houston DK, Glazer NL, Vandenput L, Peacock M, Shi J, Rivadeneira F, McCarthy MI, Anneli P, de Boer IH, Mangino M, Kato B, Smyth DJ, Booth SL, Jacques PF, Burke GL, Goodarzi M, Cheung CL, Wolf M, Rice K, Goltzman D, Hidiroglou N, Ladouceur M, Wareham NJ, Hocking LJ, Hart D, Arden NK, Cooper C, Malik S, Fraser WD, Hartikainen AL, Zhai G, Macdonald HM, Forouhi NG, Loos RJ, Reid DM, Hakim A, Dennison E, Liu Y, Power C, Stevens HE, Jaana L, Vasan RS, Soranzo N, Bojunga J, Psaty BM, Lorentzon M, Foroud T, Harris TB, Hofman A, Jansson JO, Cauley JA, Uitterlinden AG, Gibson Q, Järvelin MR, Karasik D, Siscovick DS, Econs MJ, Kritchevsky SB, Florez JC, Todd JA, Dupuis J, Hyppönen E, Spector TD. 2010. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet 376:180188.
  • Wang Z, Senn T, Kalhorn T, Zheng XE, Zheng S, Davis CL, Hebert MF, Lin YS, Thummel KE. 2011. Simultaneous measurement of plasma vitamin D(3) metabolites, including 4β,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry. Anal Biochem 418:126133.
  • Watson D, Setchell KD, Ross R. 1991. Analysis of vitamin D and its metabolites using thermospray liquid chromatography/mass spectrometry. Biomed Chromatogr 5:153160.
  • Webb AR, Hollick MF. 1988. The role of sunlight in the cutaneous production of vitamin D3. Ann Rev Nutr 8:375399.
  • Webb AR, DeCosta BR, Hollick MF. 1989. Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation. J Clin Endocrinol Metab 68:882887.
  • WHO Scientific Group on the Prevention and Management of Osteoporosis. 2003. WHO Prevention and Management of Osteoporosis: Report of a WHO Scientific Group. Geneva.
  • Wolf G. 2004. The discovery of vitamin D: The contribution of Adolf Windaus. J Nutr 134:12991302.
  • Wortsman J, Matsuoka LY, Chen TC, Lu Z, Hollick MF. 2000. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690693.
  • Xu X, Mei H, Wang S, Zhou Q, Wang G, Broske L, Pena A, Korfmacher WA. 2005. A study of common discovery dosing formulation components and their potential for causing time-dependent matrix effects in high-performance liquid chromatography tandem mass spectrometry assays. Rapid Commun Mass Spectrom 19:26432650.
  • Yates AM, Bowron A, Calton L, Heynes J, Rainbow S, Keevil B. 2008. Interlaboratory variation in 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 is significantly improved if common calibration material is used. Clin Chem 54:20802082.
  • Yergey AL, Esteban NV, Liberato DJ. 1987. Metabolic kinetics and quantitative analysis by isotope dilution thermospray LC/MS. Biomed Environ Mass Spectrom 14:623625.
  • Yetley EA, Pfeiffer CM, Schleicher RL, Phinney KW, Lacher DA, Christakos S, Eckfeldt JH, Fleet JC, Howard G, Hoofnagle AN, Hui SL, Lensmeyer GL, Massaro J, Peacock M, Rosner B, Wiebe D, Bailey RL, Coates PM, Looker AC, Sempos C, Johnson CL, Picciano MF. 2010. NHANES monitoring of serum 25-hydroxyvitamin D: A roundtable summary. J Nutr 140:2030S2045S.
  • Yeung B, Vouros P, Reddy GS. 1993. Characterization of vitamin D3 metabolites using continuous-flow fast atom bombardment tandem mass spectrometry and high-performance liquid chromatography. J Chromatogr 645:115123.
  • Young DC, Vouros P, Decosta B, Hollick MF. 1987. Location of conjugated diene position in an aliphatic chain by mass spectrometry of the 4-phenyl-1,2,4-triazoline-3,5-dione adduct. Anal Chem 59:19541957.
  • Young DC, Vouros P, Hollick MF. 1990. Gas chromatography-mass spectrometry of conjugated dienes by derivatization with 4-methyl-1,2,4-triazoline-3,5-dione. J Chromatogr 522:295302.
  • Yuan C, Kosewick J, He X, Kozak M, Wang S. 2011. Sensitive measurement of serum 1α,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction. Rapid Commun Mass Spectrom 25:12411249.
  • Zeeb H, Greinert R. 2010. The role of vitamin D in cancer prevention: Does UV protection conflict with the need to raise low levels of vitamin D? Dtsch Arztebl Int 107:638643.
  • Zerwekh JE. 2008. Blood biomarkers of vitamin D status. Am J Clin Nutr 87:10871091.